RxSight (RXST) vs Neuronetics (STIM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Neuronetics (STIM) has outperformed RxSight (RXST) over the past year, losing 25.4% versus a loss of 42.0%. Over five years, STIM leads with a -55.3% price change compared with -64.6% for RXST. RxSight is the larger company by market cap ($199.6 million vs $165.3 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | RXST | STIM |
|---|---|---|
| Share price | $4.80 | $2.17 |
| Market cap | $199.65M | $165.35M |
| 1-day change | +3.23% | -1.81% |
| YTD return | -53.93% | +57.25% |
| 1-year return | -42.03% | -25.43% |
| 5-year return | -64.60% | -55.35% |
| EPS (TTM) | $-1.14 | $-0.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.22 | $3.44 |
| 52-week low | $4.48 | $0.80 |
| Distance from 52-week high | -63.69% | -36.92% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +57.71% | +164.98% |
| Average volume | 861.88K | 2.10M |
| Shares outstanding | 41.59M | 76.20M |
| Employees | 461 | 658 |
| Sector | Health Care | Health Care |
| Industry | Ophthalmic Goods | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- STIM has outperformed RXST by 16.6 percentage points over the past year.
About RxSight
RXST stock →RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery.
Health Care · Ophthalmic Goods · 461 employees
About Neuronetics
STIM stock →Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally.
Health Care · Medical/Dental Instruments · 658 employees
RXST vs STIM FAQ
Which is bigger, RxSight or Neuronetics?
RxSight (RXST) is larger, with a market capitalization of $199.65M compared with $165.35M for Neuronetics (STIM).
Which stock has performed better over the past year, RXST or STIM?
STIM returned -25.43% over the past 12 months, compared with -42.03% for RXST (price return, excluding dividends). Past performance does not predict future results.
Are RxSight and Neuronetics in the same industry?
Both are in the Health Care sector, but in different industries: Ophthalmic Goods for RxSight and Medical/Dental Instruments for Neuronetics.